Stock Spotlight Archives

WednesdayAug 12, 2026 3:22 pm

QualityStocksNewsBreaks – Numa Numa Resources Inc. Eyes Mining Opportunities as Bougainville Charts Its Future

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. Numa Numa Resources is supporting resource development in Bougainville as the autonomous Pacific region continues discussions about its potential independence from Papua New Guinea. Following the 2019 referendum in which 97.7% of voters supported independence, economic viability remains a central consideration, with copper and gold resources representing a potentially significant source of future government revenue and development funding. A recent article highlights the legacy of the Panguna Mine and the lessons it offers regarding community participation, environmental stewardship and benefit-sharing with customary landowners. Numa Numa is working with landowner groups…

WednesdayAug 12, 2026 2:58 pm

QualityStocksNewsBreaks – Market Street Capital Inc. Highlights Importance of Exit Readiness for Founders

Market Street Capital emphasizes that founders of privately held, middle-market businesses should begin preparing for an eventual exit well before they are emotionally ready to sell. The Houston-based boutique capital markets and financial advisory firm says exit readiness involves understanding market conditions and valuations, strengthening financial and operational performance, organizing records, addressing potential due diligence concerns and building management depth before entering a sale process. With middle-market M&A valuations and exit activity showing strength, the firm argues that well-prepared founders may be better positioned to capture value and negotiate favorable terms. Market Street Capital’s advisory and M&A practices are designed to…

WednesdayAug 12, 2026 1:10 pm

QualityStocksNewsBreaks – SS Innovations International Inc. (NASDAQ: SSII) Earns Industry Recognition as SSi Mantra Adoption Expands

SS Innovations International (NASDAQ: SSII) was named the Outstanding Company at the 2026 Surgical Robotics Industry Awards, selected from 10 finalists that included several established medical technology and surgical robotics companies. The recognition comes as the company continues expanding adoption of its SSi Mantra surgical robotic platform, which had supported 11,719 procedures globally as of June 22, 2026, across more than 170 procedure types and multiple specialties. Approximately 2,100 physicians have been trained on the system, while regulatory approvals in 14 countries support the company’s international expansion strategy. SSi Mantra features a modular, multi-arm design, 3D 4K visualization and more than…

MondayAug 10, 2026 3:30 pm

QualityStocksNewsBreaks – Greenland Mines Ltd. (NASDAQ: GRML) Pursues Strategic Growth in Emerging Critical Minerals Region

Greenland Mines (NASDAQ: GRML) is pursuing a diversified critical minerals strategy focused on Greenland as demand for resources essential to electric vehicles, renewable energy, semiconductors, advanced computing and defense technologies continues to grow. The company aims to build a portfolio of projects spanning multiple strategically important commodities rather than relying on a single mineral, while also pursuing acquisitions and partnerships to expand its position. A recent article highlights Greenland’s substantial geological potential and growing international attention as governments seek more secure and diversified mineral supply chains. Greenland Mines plans to advance prospective assets through exploration and geological evaluation while emphasizing responsible…

MondayAug 10, 2026 2:43 pm

QualityStocksNewsBreaks – Forward Industries Inc. (NASDAQ: FWDI) Expands Solana Holdings and Institutional Capital Access

Forward Industries (NASDAQ: FWDI) expanded its Solana treasury by more than 500,000 SOL during fiscal Q3 2026 at an average purchase price of approximately $79 per SOL, bringing its holdings to 7.55 million SOL as of June 30. The company also sold 93,642 shares through its at-the-market offering while reporting 36% annualized SOL-per-share growth, which it says demonstrates its ability to raise capital in an accretive manner. Following inclusion in the Russell 2000 and Russell 3000 indexes, Forward says it has additional access to institutional capital, while its proprietary fwdSOL staking token provides another source of liquidity. To view the full…

FridayAug 07, 2026 2:55 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones

Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory and commercial milestones amid growing interest in regenerative orthopedic solutions. GelrinC is an off-the-shelf, cell-free implant designed for a streamlined, single-step procedure that supports cartilage regeneration without the cell harvesting and laboratory processing required by some alternative approaches. Regentis is continuing enrollment in its U.S. clinical study, preparing for a potential FDA Premarket Approval submission, expanding commercialization efforts in Europe following CE Mark approval, and optimizing manufacturing for scalability and consistency. To view the full article, visit https://ibn.fm/mVCsB About Regentis Biomaterials Ltd. Regentis Biomaterials is a…

FridayAug 07, 2026 2:12 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Two-Pronged Approach to Neurological Health

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), a biopharmaceutical company focused on advancing innovative therapies and technologies, is developing a two-pronged strategy addressing neurological health through its investigational multiple sclerosis therapy Lucid-MS and its proprietary dietary supplement unbuzzd. Lucid-MS is designed to target PAD2, an enzyme associated with myelin degradation, with the goal of protecting and potentially restoring the myelin sheath rather than primarily modulating the immune system. The company submitted an IND application to the FDA for a Phase 2 trial and is supporting development through an imaging collaboration…

FridayAug 07, 2026 1:04 pm

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Builds Strategic Position in Antibody Therapeutics Market

VERAXA Biotech (NASDAQ: VRXA) is developing next-generation antibody therapeutics across antibody-drug conjugates (“ADCs”) and T-cell engagers (“TCEs”), two areas that continue to attract significant pharmaceutical investment. A recent article highlights major transactions to illustrate how differentiated antibody-engineering platforms can attract substantial financial commitments even before clinical development reaches advanced stages. VERAXA’s proprietary BiTAC platform supports a pipeline that includes bispecific ADCs, T-cell engagers and engineered antibody formats, potentially creating opportunities for future platform partnerships, licensing agreements or asset-level transactions. To view the full article, visit https://ibn.fm/sMjlp About VERAXA Biotech AG VERAXA is building a premier engine for the discovery and development of…

WednesdayAug 05, 2026 1:54 pm

QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Expands Project Holdings in Prolific Abitibi Belt

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) was featured in a recent article that discussed its efforts to expand its gold project holdings in Québec’s prolific Abitibi Greenstone Belt through the acquisition of 27 mineral claims totaling approximately 701 hectares adjacent to its McKenzie East Project. The transaction increases LaFleur’s overall Abitibi land position to more than 23,100 hectares across 490 claims and adds ground containing a historical Maruska gold showing, which the company plans to explore through data compilation, drilling and other exploration activities. Meanwhile, LaFleur is…

WednesdayAug 05, 2026 1:15 pm

QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) Combines Targeted Cancer Therapy, Nanotechnology and AI

Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) is pursuing an integrated approach to cancer drug development that combines three emerging areas: PNKP-targeted DNA damage response (“DDR”) inhibition, nanoparticle drug delivery and artificial intelligence. Its lead candidate, ONC010, pairs a PNKP inhibitor with a polymer micelle carrier intended to improve drug solubility, tumor accumulation and tolerability, while the company’s Inka Health subsidiary is developing the SynoGraph causal AI platform to support patient selection, clinical trial design and evidence generation. The company is advancing ONC010 through preclinical, manufacturing and IND-enabling…

Site Search

Company Search

Category: Stock Spotlight